Necrotizing Fasciitis caused by Streptococcus pyogenes: A case report and literature review of disease diagnosis and management

Main Article Content

Hassan A Aziz*

Abstract



Background: A 55-year-old male presented to the emergency room at a local hospital complaining of chest discomfort and severe left elbow pain.


Case Presentation: Erythema and symptoms of peripheral neuropathy were evident in the left hand. The patient reported recent trauma to his left elbow; however a radiograph of the left arm was unremarkable for fracture. After being admitted to the intensive care unit for observation, he developed worsening pain out of proportion and progressive decreased sensation in his left hand.


Diagnosis: Initially, left arm compartment syndrome was suspected and treated accordingly. After surgical intervention, the patient’s subsequent symptoms and preliminary blood culture results revealed Gram positive cocci in chains, indicating necrotizing fasciitis. The isolate was identified as group A beta-hemolytic Streptococcus (GABS).


Treatment and Follow-up: Broad-spectrum antibiotics given at outset were extended with additional antibiotics. Treatment consisted of five separate surgeries involving extensive debridement of necrotic tissue amounting to approximately 55 to 65 percent of the patient’s body surface area. The patient was eventually released to a burn center for skin grafting and wound closure and in less than three months, he expired.



Downloads

Download data is not yet available.

Article Details

Aziz, H. A. (2017). Necrotizing Fasciitis caused by Streptococcus pyogenes: A case report and literature review of disease diagnosis and management. Archives of Community Medicine and Public Health, 3(2), 058–061. https://doi.org/10.17352/2455-5479.000026
Case Reports

Copyright (c) 2017 Aziz HA.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Hidalgo-Grass C, Dan-Goor M, Maly A, Eran Y, Kwinn LA, et al. (2004) Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. The Lancet 363, 696. Link: https://goo.gl/R78qw2

Kihiczak GG, Schwartz RA, Kapila R (2006) Necrotizing fasciitis: a deadly infection. J Eur Acad Dermatol Venereol 20: 365-369. Link: https://goo.gl/QLZjJF

Anderson JM (2011) Necrotizing fasciitis: An uncommon disease, frequently misdiagnosed. Journal of Controversial Medical Claims 11: 7-11. Link:

Vayvada H, Demirdover C, Menderes A, Karaca C (2012) [Necrotizing fasciitis: diagnosis, treatment and review of the literature]. Ulus Travma Acil Cerrahi Derg 18: 507-513. Link: https://goo.gl/5cbHfn

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, et al. (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41, 1383-84. Link: https://goo.gl/WVoM2V

Olsen RJ, Shelburne SA, Musser JM (2009) Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 11: 4-9. Link: https://goo.gl/J2gNzC

Barillo DJ1, McManus AT, Cancio LC, Sofer A, Goodwin CW (2003) Burn center management of necrotizing fasciitis. J Burn Care Rehabil 24: 127-132. Link: https://goo.gl/ADLEYi

Swain RA, Hatcher JC, Azadian BS, et al. (2013) A five-year review of necrotising fasciitis in a tertiary referral unit. Ann R Coll Surg Engl 95: 57-60. Link: https://goo.gl/APGC19

McKenzie SB, Williams JL (2010) Clinical laboratory hematology, (2nd ed.) Upper Saddle river, NJ: Pearson, 386-387. Link: https://goo.gl/uh474H

Musialkowska E, Jedynak M, Klepacki A, Musiuk T, Wilkowska-Trojniel M, et al. (2010) Multifocal necrotizing fasciitis - case report. Adv Med Sci 55: 103-106. Link: https://goo.gl/FpuetM

Musser JM, Shelburne III SA (2009) A decade of molecular pathogenomic analysis of group A streptococcus. J Clin Invest 119: 2456-2463. Link: https://goo.gl/rKSghr